Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of chemotherapy

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/joc.2010.22.3.201PMID 20566427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.

  2009cited by this paper
• Maintenance treatment in metastatic breast cancer

  2008cited by this paper
• Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer.

  2007cited by this paper
• Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Letrozole or Anastrozole. A Phase II Trial Conducted by the Hellenic Group of Oncology (HELGO)

  2006cited by this paper
• A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients.

  2006cited by this paper
• Metronomic low‐dose chemotherapy as antiangiogenic therapeutic strategy for cancer

  2005cited by this paper
• Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

  2005cited by this paper
• Megestrol acetate for the treatment of anorexia-cachexia syndrome.

  2005cited by this paper
• Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.

  2004cited by this paper
• Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens

  2002cited by this paper
• Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer

  2002cited by this paper
• Metronomic scheduling: the future of chemotherapy?

  2001cited by this paper
• Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.

  2001cited by this paper
• Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.

  2001cited by this paper
• Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.

  1998cited by this paper
• Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.

  1997cited by this paper
• Cisplatin and VP16 in Metastatic Breast Carcinoma as a Third-Line Chemotherapy: A Randomized Study Comparing Low versus High Doses of Cisplatin

  1995cited by this paper
• Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.

  1994cited by this paper
• An overview of megestrol acetate for the treatment of advanced breast cancer.

  1988cited by this paper

• Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer

  2025cites this paper
• Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase III MECCA Trial

  2025cites this paper
• "Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities".

  2024cites this paper
• Low-grade serous ovarian cancer with BRAFV600E mutation treated with metronomic chemotherapy — a case report and literature review

  2023cites this paper
• Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study

  2021influential citation
• Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?

  2020cites this paper
• Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors.

  2020cites this paper
• Achievements and challenges in the use of metronomics for the treatment of breast cancer.

  2020cites this paper
• Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects

  2020cites this paper
• Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer

  2020cites this paper
• Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience

  2019cites this paper
• Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy

  2019cites this paper
• Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

  2018cites this paper
• Chemotherapy and HER2-Directed Therapy for Metastatic Breast Cancer

  2018cites this paper
• Hormone Therapy in Breast Cancer: Where do We Stand?

  2017cites this paper
• Current achievements and future perspectives of metronomic chemotherapy

  2017cites this paper
• The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis

  2017cites this paper
• Metronomic chemotherapy for advanced breast cancer patients.

  2017cites this paper
• Treatment of Metastatic Breast Cancer: Chemotherapy

  2016cites this paper
• Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer.

  2016cites this paper
• Metronomic chemotherapy for metastatic breast cancer – a systematic review of the literature

  2016cites this paper
• Adjuvant chemotherapy of megestrol acetate in advanced breast cancer: A meta-analysis

  2015cites this paper
• DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells

  2015cites this paper
• Clinical overview of metronomic chemotherapy in breast cancer

  2015cites this paper
• Metronomic therapy and breast cancer: a systematic review.

  2014cites this paper
• Metronomic Chemotherapy in Breast Cancers

  2014cites this paper
• Metronomic chemotherapy for cancer treatment: a decade of clinical studies

  2013cites this paper
• LC-MS/MS method for determination of megestrol in human plasma and its application in bioequivalence study

  2013cites this paper
• Metronomic anti-cancer therapy - an ongoing treatment option for advanced cancer patients

  2012cites this paper
• Remarkable Effect of Metronomic Chemotherapy in Diffuse Lung Metastases of Thyroid Cancer

  2012cites this paper